UK's Pentair raises annual profit forecast on favorable market trends
The company now expects 2025 adjusted earnings between $4.75 and $4.85 per share, up from its previous view of $4.65 to $4.80 per share, versus analysts' estimate of $4.76 per share, according to data compiled by LSEG.
"We are well positioned to capture opportunities from favorable secular trends in water availability, increased awareness of water challenges, aging commercial, public and municipal infrastructure, outdoor healthy living and favorable housing migration," CEO John Stauch said.
Stauch added that the company is ready to capture higher demand once the residential market returns to growth.
The UK-based company provides residential and industrial water technology products and services across 150 countries. It operates through three segments – Industrial & Flow Technologies, Water Solutions, and Pool.
Pentair makes filtration products for a range of industries, along with water pump solutions used in flood control, fire suppression, and residential applications. It also produces pumps, heating systems, and LED lighting for swimming pools, as well as water filtration systems for household use.
The company reported an adjusted profit of $1.39 per share for the quarter ended June 30, above analysts' estimates of $1.34 per share.
Quarterly revenue rose 2.2% to $1.12 billion, in line with analysts' estimates.
Pentair previously implemented price hikes and pre-purchased its inventory to offset any potential impact from President Donald Trump's tariff policies, while also taking steps to reduce its dependence on China for its supply chain needs.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Reuters
6 minutes ago
- Reuters
Indian drugmaker Cipla beats first-quarter profit view on higher domestic demand
July 25 (Reuters) - Cipla ( opens new tab, India's third-largest drugmaker by sales, reported a better-than-expected quarterly profit on Friday, driven by higher domestic demand for its generic respiratory drugs. The company's consolidated net profit rose 10% to 12.98 billion rupees ($150 million) in the April-June quarter, beating analysts' average estimate of 12.11 billion rupees, per data compiled by LSEG. Total revenue increased 4% to 69.57 billion rupees, slightly below expectations of 70.64 billion rupees. Cipla's shares jumped 3.4% after the results and were set for their best day in nearly three months. The stock was the top gainer on the blue-chip Nifty 50 index (.NSEI), opens new tab. Revenue from India, Cipla's biggest market by sales, climbed 6% to 30.70 billion rupees, while North America revenue fell 7% to 19.33 billion rupees. The two regions account for three-fourths of the company's total sales. Cipla said growth in India was led by demand for drugs in therapy areas such as respiratory, urology and anti-infectives. However, delayed approvals for new drug applications and pricing pressure have weighed on the drugmaker's growth in the U.S. Drug prices in the U.S. are expected to drop as shortages ease and competition from new drugmakers intensifies, Macquarie analysts said in a pre-earnings note. Earlier this week, rival Dr Reddy's ( opens new tab missed quarterly profit estimates and flagged increased price erosion in certain key products, including lenalidomide in North America. ($1 = 86.5750 Indian rupees)
.jpeg%3Fwidth%3D1200%26auto%3Dwebp%26quality%3D75%26trim%3D221%2C0%2C2219%2C0%26crop%3D&w=3840&q=100)
Scotsman
36 minutes ago
- Scotsman
How premium logistics can power Scotland's exports
Mark Rosenberg | Supplied Ask a Scot to name their finest food and drink export and you're likely to spark a fierce debate, says Mark Rosenberg, Chief Commercial Officer, Ports & Terminals, at DP World Sign up to our daily newsletter – Regular news stories and round-ups from around Scotland direct to your inbox Sign up Thank you for signing up! Did you know with a Digital Subscription to The Scotsman, you can get unlimited access to the website including our premium content, as well as benefiting from fewer ads, loyalty rewards and much more. Learn More Sorry, there seem to be some issues. Please try again later. Submitting... Whatever their preference, everyone can agree that the sector is a phenomenal global success story. The numbers speak for themselves. Last year, Scotland's food and drink exports were valued at £7.1 billion. That's up from £4.9bn in 2014, an increase of roughly 46 per cent over the past decade. This is driven by a strong appetite for its premium produce, such as Scottish salmon which had shipments topping £844 million in 2024. More than a key contributor to the UK economy, Scotland's food and drink industry has become a global benchmark for excellence. However, despite extraordinary market growth, exporters are not immune from trade challenges. Post-Brexit border friction, fluctuating global tariffs and shifting consumer expectations have all made the operating environment increasingly volatile in recent years. The good news is that new trade opportunities are opening routes to growth at a critical moment. Most notably, the UK-India Free Trade Agreement, which was signed yesterday (24 July). By cutting levies on 90 per cent of the produce from Scottish exporters - and those elsewhere in the UK - the landmark deal will transform the presence of the UK's exports in India. This is especially promising for food products like Scottish salmon, which have faced prohibitive 33 per cent tariffs. Once they are lifted, exporters will have access to the world's third-largest fish market and a middle class that is expected to grow to a quarter of a billion by 2050. Understandably, many are preparing for significant long-term expansion into the market. Logistics to power exports | Supplied Premium produce requires premium logistics While the potential for growth in both nearby and distant markets is clear, capturing these opportunities depends on the essential but less glamourous matter of logistics. Ageing infrastructure can increase costs and add complexity. Scotland has felt these constraints acutely. However, the challenges also present opportunities for strategic partnerships that can deliver far greater efficiencies across the supply chain. At DP World, we're not shy of the challenge and have invested to ensure UK exporters can seize the trade opportunities of the day. Our deep sea container ports connect exporters across the whole of the UK with overseas markets. In 2013, we opened London Gateway - the UK's first deep-water container port for more than 20 years - and have committed to its growth ever since. Just a few months ago we began work on a £1 billion expansion of its port facilities and rail infrastructure and announced a further £60 million investment in the Port of Southampton. Both will boost handling capacity and improve direct rail services, offering Scottish exporters fast, low-carbon routes to global shipping networks. As exporters hurry to capitalise on the new opportunities, undoubtedly there will be many pitfalls to navigate, whether that's complex regulatory challenges, untested consumer appetites and cultural nuance. That's where the right logistics infrastructure becomes a critical enabler. Labelling and packaging requirements, for example, vary by market and can create bottlenecks if not handled with care - something DP World supports through advanced, market-specific compliance services. Untested consumer appetites also mean shipments need to be agile, fresh and first-class. In this case facilities like The Chill Hub, our temperature-controlled warehouse at London Gateway, are indispensable for high-value perishable goods like Scottish salmon. Alongside connectivity and adaptability, exporters need flexibility. With rail or barge connectivity at 95 per cent of our 20 European sites, Scottish producers have the necessary options to move goods effectively and on schedule should congestion occur. This is an area we continue to invest in, helping to build the resilience that traders will need for the decades ahead. Scotland's food and drink exporters have a long and proud history, but with new trade agreements opening doors to major, high-growth markets like India, this feels like the start of an exciting new chapter. By strengthening the logistics networks and alliances that move goods from A to B, we can help the blue-and-white 'Made in Scotland' label find new admirers around the world. That's an opportunity we can all raise a glass to.
Reuters
36 minutes ago
- Reuters
Indian drugmaker Cipla beats first-quarter profit view
July 25 (Reuters) - Cipla ( opens new tab, India's No. 3 drugmaker by sales, reported a first-quarter profit that beat market expectations on Friday. The company's consolidated net profit increased 10% to 12.98 billion rupees ($150 million) in the April-June quarter, beating analysts' estimates of 12.11 billion rupees, per data compiled by LSEG. ($1 = 86.5750 Indian rupees)
